Back to funds
View filing
ORBIMED ADVISORS LLC
Updated 6 days agoManaged by Orbimed Advisors Llc • Latest filing Q3 2026
Portfolio value
$5.5B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
99.2%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 4 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q4 2025 | $4.9B |
| Q1 2026 | $5B |
| Q2 2026 | $5.4B |
| Q3 2026 | $5.5B |
Top holdings
124 positions as of Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | $630.1M | 15.52M | 11.46% | — | |
| 2 | $482.7M | 24.21M | 8.78% | — | |
| 3 | $310.6M | 6.78M | 5.65% | — | |
| 4 | $298.4M | 257.9K | 5.43% | — | |
| 5 | ? N/A BRAVEHEART BIO INC | $245.9M | 12.18M | 4.47% | — |
| 6 | $195.5M | 2.72M | 3.56% | — | |
| 7 | $180.2M | 3.07M | 3.28% | — | |
| 8 | $137.5M | 946.1K | 2.50% | — | |
| 9 | $104.2M | 584.1K | 1.89% | — | |
| 10 | $91.7M | 3.03M | 1.67% | — | |
| 11 | $82.5M | 7.17M | 1.50% | — | |
| 12 | $82.5M | 199.7K | 1.50% | — | |
| 13 | $82.5M | 3.12M | 1.50% | — | |
| 14 | $81.3M | 120.4K | 1.48% | — | |
| 15 | $80.4M | 219.0K | 1.46% | — | |
| 16 | $78.6M | 345.2K | 1.43% | — | |
| 17 | ? N/A ELECTRA THERAPEUTICS INC | $77.5M | 6.89M | 1.41% | — |
| 18 | $72.1M | 75.2K | 1.31% | — | |
| 19 | $72.1M | 834.9K | 1.31% | — | |
| 20 | $70.7M | 1.20M | 1.29% | — |